Difference between revisions of "Shirihai Orian"
From Bioblast
Tindle Lisa (talk | contribs) |
|||
Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=Shirihai | |lastname=Shirihai | ||
|firstname=Orian | |firstname=Orian | ||
|title=MD, PhD, Professor, Molecular and Medical Pharmacology | |title=MD, PhD, Professor, Molecular and Medical Pharmacology | ||
|institution=[[File:Shirihai_O.jpg|right|150px]]Dept. Molecular and Medical Pharmacology33-131E Center for Health SciencesUniversity of California, Los Angeles, UCLA | |||
|institution= | |||
[[File:Shirihai_O.jpg|right|150px]] | |||
Dept. Molecular and Medical | |||
|address=10833 Le Conte Ave | |address=10833 Le Conte Ave | ||
|area code=90095 | |area code=90095 | ||
Line 18: | Line 10: | ||
|country=USA | |country=USA | ||
|weblink=https://profiles.ucla.edu/orian.shirihai | |||
}} | |||
{{Labelingperson | |||
|field of research=Basic, Pharmacological | |||
}} | }} | ||
{{MITOEAGLE}} | |||
== Participated at == | == Participated at == | ||
Line 24: | Line 22: | ||
::::* [[MiPNet28.03 IOC157 Los Angeles US |2023 O2k-Workshop UCLA]] | ::::* [[MiPNet28.03 IOC157 Los Angeles US |2023 O2k-Workshop UCLA]] | ||
::::* [[MiP2014| MiP2014 Obergurgl AT]] | ::::* [[MiP2014| MiP2014 Obergurgl AT]] | ||
Revision as of 09:29, 14 December 2023
Name | Shirihai Orian, MD, PhD, Professor, Molecular and Medical Pharmacology |
---|---|
Institution | Dept. Molecular and Medical Pharmacology33-131E Center for Health SciencesUniversity of California, Los Angeles, UCLA |
Address | 10833 Le Conte Ave, 90095 |
City | Los Angeles |
State/Province | California (CA) |
Country | USA |
[email protected] | |
Weblink | https://profiles.ucla.edu/orian.shirihai |
O2k-Network Lab | US CA Los Angeles Shirihai O |
Labels:
Field of research: Basic, Pharmacological
Publications
Published | Reference | |
---|---|---|
Rodriguez-Nuevo 2018 EMBO J | 2018 | Rodríguez-Nuevo A, Díaz-Ramos A, Noguera E, Díaz-Sáez F, Duran X, Muñoz JP, Romero M, Plana N, Sebastián D, Tezze C, Romanello V, Ribas F, Seco J, Planet E, Doctrow SR, González J, Borràs M, Liesa M, Palacín M, Vendrell J, Villarroya F, Sandri M, Shirihai O, Zorzano A (2018) Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. EMBO J 37. |
Abstracts
Published | Reference | |
---|---|---|
Shirihai 2023 MiP2023 | 2023 | Inhibition of ATP synthase hydrolytic activity restores cellular energy homeostasis in conditions of impaired respiration. |
Cerqueira 2016 Abstract Mito Xmas Meeting Innsbruck | 2016 | The Deubiquitinating (DUB) protein Ubiquitin carboxyl- terminal hydrolase L1 (UCH-L1) regulates Mitofusin-2 levels and mitochondrial function in mammalian cell lines and in D. Melanogaster. |
Shirihai 2014 Abstract MiP2014 | 2014 | Mitochondrial dynamics and quality control, a conflict of interest. |
Trudeau 2014 Abstract MiP2014 | 2014 | Role of mitochondrial fusion and motility in distributing young mitochondrial protein and removing old protein from the mitochondrial network. |
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Shirihai Orian